Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Insulin: Biosynthesis, Chemistry, and Preparation

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Acute Psychiatric Care Provision for Children and Adolescents in Ireland.

Irish medical journal·2026

Same author

Long term endocrine issues in adults born prematurely: a systematic review.

Frontiers in pediatrics·2025

Same author

Intervention to promote adolescents' communication and engagement in diabetes clinic encounters: A pilot randomized controlled trial.

Patient education and counseling·2024

Same author

Including 8 hours of access to alfalfa in 1 or 2 grazing sessions in dairy cows fed a partial mixed ration: Effects on intake, behavior, digestion, and milk production and composition.

Journal of dairy science·2023

Same author

Plant compounds for obesity treatment through neuroendocrine regulation of hunger: A systematic review.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2023

Same author

Socio-demographic and clinical characteristics of migrants to Ireland presenting with a first episode of psychosis.

Irish journal of psychological medicine·2021

Search research articles

Related Experiment Video

Updated: Jul 18, 2026

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells

Published on: February 2, 2024

Insulin-producing cells derived from stem cells: recent progress and future directions.

A Santana¹, R Enseñat-Waser, María Isabel Arribas

¹Genetic and Cytogenetic Unit, Childhood Hospital of Canary Islands, Las Palmas, Spain.

Journal of Cellular and Molecular Medicine

|November 28, 2006

Summary

Stem cells offer a promising avenue for generating insulin-producing cells to treat diabetes. However, challenges remain in achieving beta-cell similarity, immune compatibility, and preventing tumor formation for clinical application.

More Related Videos

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

Related Experiment Videos

Last Updated: Jul 18, 2026

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells

Published on: February 2, 2024

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

Area of Science:

Endocrinology and Regenerative Medicine
Stem Cell Biology
Diabetes Research

Background:

Type 1 diabetes involves autoimmune destruction of pancreatic beta-cells.
Type 2 diabetes presents complex pathology including beta-cell loss, dedifferentiation, and insulin resistance.
Current insulin therapy for diabetes lacks precise glycemic control, leading to secondary complications.

Purpose of the Study:

To review methods for generating insulin-producing cells from embryonic and adult stem cells.
To identify key challenges hindering the clinical application of stem cell-derived therapies for diabetes.

Main Methods:

Review of existing literature on stem cell differentiation protocols for beta-cell generation.
Analysis of studies demonstrating the efficacy of stem cell-derived insulin-producing cells in animal models.
Examination of challenges related to cell characterization, immune rejection, and tumorigenesis.

Main Results:

Stem cells, including embryonic and adult progenitors, can be differentiated into insulin-producing cells in vitro.
These derived cells have shown potential in reversing experimental diabetes in animal models.
Significant hurdles persist, including achieving true pancreatic beta-cell identity and ensuring long-term safety and efficacy.

Conclusions:

Stem cell-based generation of insulin-producing cells represents a potential therapeutic strategy for diabetes.
Further research is crucial to overcome challenges in cell differentiation, immune compatibility, and tumor suppression.
Clinical translation requires robust protocols ensuring the generation of functional and safe beta-like cells.